By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Ember Therapeutics 

29 Newbury Street

Boston  Massachusetts  02116  U.S.A.
Phone: n/a Fax: n/a


Company News
Ember Therapeutics Announce Initial Positive Results From A Phase 2 Trial Of BMP-7 In Patients With Moderate Osteoarthritis Of The Knee 10/20/2015 7:47:53 AM
Ember Therapeutics and Third Rock Ventures — A Case Study in the Risks of Biotech Investments 9/10/2015 6:31:49 AM
Ember Therapeutics Raises Up To $6M And Establishes Commercial Partnership With Knight Therapeutics 8/7/2015 6:18:39 AM
Ember Therapeutics And Mariel Therapeutics Enter Definitive Merger Agreement Creating A Strong Diversified Company 3/12/2015 7:01:07 AM
Ember Therapeutics Broadens Brown Fat Small Molecule Drug Discovery Portfolio, Secures Exclusive License Options to Intellectual Property for Three Small Molecule Targets 10/4/2012 10:10:55 AM
Ember Therapeutics Announces Cell Publication of Key Data Showing TRPV4 Inhibition Activates Brown/Beige Fat and Protects Against Obesity, Inflammation and Insulin Resistance 9/27/2012 10:26:57 AM
Ember Therapeutics Expands Scientific Leadership to Advance Metabolic Pipeline 5/30/2012 9:56:52 AM
Pure Communications Release: Ember Therapeutics Secures Exclusive License to Key Brown Fat Technology and Intellectual Property from the Joslin Diabetes Center 3/28/2012 6:52:41 AM
Ember Therapeutics Launched with $34 Million to Focus on Metabolic Disorders 12/15/2011 6:37:33 AM